MediWound (MDWD) Competitors $19.12 -0.08 (-0.42%) Closing price 07/2/2025 04:00 PM EasternExtended Trading$19.14 +0.02 (+0.10%) As of 07/2/2025 04:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MDWD vs. COGT, SNDX, CMRX, CDMO, ORIC, QURE, AVXL, IMNM, GYRE, and PHATShould you be buying MediWound stock or one of its competitors? The main competitors of MediWound include Cogent Biosciences (COGT), Syndax Pharmaceuticals (SNDX), Chimerix (CMRX), Avid Bioservices (CDMO), Oric Pharmaceuticals (ORIC), uniQure (QURE), Anavex Life Sciences (AVXL), Immunome (IMNM), Gyre Therapeutics (GYRE), and Phathom Pharmaceuticals (PHAT). These companies are all part of the "pharmaceutical products" industry. MediWound vs. Its Competitors Cogent Biosciences Syndax Pharmaceuticals Chimerix Avid Bioservices Oric Pharmaceuticals uniQure Anavex Life Sciences Immunome Gyre Therapeutics Phathom Pharmaceuticals MediWound (NASDAQ:MDWD) and Cogent Biosciences (NASDAQ:COGT) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, valuation, institutional ownership, profitability and risk. Do institutionals & insiders hold more shares of MDWD or COGT? 46.8% of MediWound shares are held by institutional investors. 9.2% of MediWound shares are held by insiders. Comparatively, 7.3% of Cogent Biosciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has more risk & volatility, MDWD or COGT? MediWound has a beta of 0.32, suggesting that its share price is 68% less volatile than the S&P 500. Comparatively, Cogent Biosciences has a beta of 1.88, suggesting that its share price is 88% more volatile than the S&P 500. Is MDWD or COGT more profitable? Cogent Biosciences has a net margin of 0.00% compared to MediWound's net margin of -110.45%. MediWound's return on equity of -74.12% beat Cogent Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets MediWound-110.45% -74.12% -30.92% Cogent Biosciences N/A -149.79%-75.61% Which has preferable valuation & earnings, MDWD or COGT? MediWound has higher revenue and earnings than Cogent Biosciences. MediWound is trading at a lower price-to-earnings ratio than Cogent Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMediWound$20.22M10.22-$30.22M-$2.09-9.15Cogent BiosciencesN/AN/A-$255.86M-$1.84-4.03 Do analysts prefer MDWD or COGT? MediWound currently has a consensus price target of $31.80, suggesting a potential upside of 66.32%. Cogent Biosciences has a consensus price target of $14.43, suggesting a potential upside of 94.72%. Given Cogent Biosciences' higher probable upside, analysts plainly believe Cogent Biosciences is more favorable than MediWound.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MediWound 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Cogent Biosciences 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.75 Does the media favor MDWD or COGT? In the previous week, Cogent Biosciences had 2 more articles in the media than MediWound. MarketBeat recorded 5 mentions for Cogent Biosciences and 3 mentions for MediWound. Cogent Biosciences' average media sentiment score of 1.01 beat MediWound's score of 0.79 indicating that Cogent Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment MediWound 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cogent Biosciences 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryMediWound and Cogent Biosciences tied by winning 8 of the 16 factors compared between the two stocks. Get MediWound News Delivered to You Automatically Sign up to receive the latest news and ratings for MDWD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MDWD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDWD vs. The Competition Export to ExcelMetricMediWoundMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$207.51M$2.42B$5.54B$8.87BDividend YieldN/A1.77%5.39%4.10%P/E Ratio-9.158.7226.1719.90Price / Sales10.22663.86414.67113.66Price / CashN/A151.5836.1356.90Price / Book6.624.548.055.38Net Income-$30.22M$31.16M$3.15B$248.50M7 Day Performance-2.05%0.15%1.85%2.97%1 Month Performance-14.03%8.81%4.81%6.02%1 Year Performance22.88%2.55%34.86%20.39% MediWound Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDWDMediWound1.8184 of 5 stars$19.12-0.4%$31.80+66.3%+22.9%$207.51M$20.22M-9.1580News CoverageCOGTCogent Biosciences2.5549 of 5 stars$7.26+0.4%$14.57+100.7%-10.1%$823.18MN/A-3.9580Positive NewsAnalyst ForecastAnalyst RevisionSNDXSyndax Pharmaceuticals3.1224 of 5 stars$9.19-3.1%$35.91+290.7%-56.4%$815.73M$23.68M-2.38110Positive NewsCMRXChimerix0.6672 of 5 stars$8.54flat$8.53-0.1%N/A$801.09M$212K-9.0990CDMOAvid Bioservices0.914 of 5 stars$12.50+0.1%$12.25-2.0%+86.5%$799.18M$139.91M-5.23320News CoverageHigh Trading VolumeORICOric Pharmaceuticals4.2182 of 5 stars$10.00+7.4%$19.17+91.7%+41.6%$793.44MN/A-5.3580QUREuniQure2.3751 of 5 stars$13.95-1.8%$37.82+171.1%+256.1%$778.36M$27.12M-3.18500News CoverageAVXLAnavex Life Sciences3.9086 of 5 stars$9.30+2.3%$44.00+373.1%+155.9%$776.03MN/A-16.9140News CoverageIMNMImmunome2.4753 of 5 stars$8.74-0.1%$23.33+167.0%-26.2%$761.36M$9.04M-2.7540Positive NewsGYREGyre Therapeutics0.204 of 5 stars$7.77-3.7%N/A-35.4%$756.62M$105.76M388.6940PHATPhathom Pharmaceuticals4.0549 of 5 stars$9.47-9.1%$17.50+84.8%-13.1%$727.46M$55.25M-1.81110High Trading Volume Related Companies and Tools Related Companies Cogent Biosciences Alternatives Syndax Pharmaceuticals Alternatives Chimerix Alternatives Avid Bioservices Alternatives Oric Pharmaceuticals Alternatives uniQure Alternatives Anavex Life Sciences Alternatives Immunome Alternatives Gyre Therapeutics Alternatives Phathom Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MDWD) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And th...Weiss Ratings | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredA grave, grave error.President Donald Trump made headlines last month with a staggering claim. He stated that since taking offic...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediWound Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share MediWound With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MDWD Stock Alerts